These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15911701)

  • 1. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
    Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
    Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves.
    Kasimir MT; Rieder E; Seebacher G; Nigisch A; Dekan B; Wolner E; Weigel G; Simon P
    J Heart Valve Dis; 2006 Mar; 15(2):278-86; discussion 286. PubMed ID: 16607912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
    Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
    Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves.
    Tudorache I; Cebotari S; Sturz G; Kirsch L; Hurschler C; Hilfiker A; Haverich A; Lichtenberg A
    J Heart Valve Dis; 2007 Sep; 16(5):567-73; discussion 574. PubMed ID: 17944130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation.
    Kasimir MT; Weigel G; Sharma J; Rieder E; Seebacher G; Wolner E; Simon P
    Thromb Haemost; 2005 Sep; 94(3):562-7. PubMed ID: 16268473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of decellularization on tissue composition and immunogenicity of porcine and human aortic valves].
    Jian XH; Lin QX
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):2039-42. PubMed ID: 22200708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix.
    Wilcox HE; Korossis SA; Booth C; Watterson KG; Kearney JN; Fisher J; Ingham E
    J Heart Valve Dis; 2005 Mar; 14(2):228-36; discussion 236-7. PubMed ID: 15792184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG deposition and activation of the classical complement pathway involvement in the activation of human granulocytes by decellularized porcine heart valve tissue.
    Bastian F; Stelzmüller ME; Kratochwill K; Kasimir MT; Simon P; Weigel G
    Biomaterials; 2008 Apr; 29(12):1824-32. PubMed ID: 18258297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds.
    Iop L; Renier V; Naso F; Piccoli M; Bonetti A; Gandaglia A; Pozzobon M; Paolin A; Ortolani F; Marchini M; Spina M; De Coppi P; Sartore S; Gerosa G
    Biomaterials; 2009 Sep; 30(25):4104-16. PubMed ID: 19481252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
    Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro assessment of the functional performance of the decellularized intact porcine aortic root.
    Korossis SA; Wilcox HE; Watterson KG; Kearney JN; Ingham E; Fisher J
    J Heart Valve Dis; 2005 May; 14(3):408-21; discussion 422. PubMed ID: 15974537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte-based immune response against decellularized or glutaraldehyde cross-linked vascular tissue.
    Rieder E; Nigisch A; Dekan B; Kasimir MT; Mühlbacher F; Wolner E; Simon P; Weigel G
    Biomaterials; 2006 Nov; 27(33):5634-42. PubMed ID: 16889827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
    Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
    Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomechanical properties of decellularized porcine pulmonary valve conduits.
    Seebacher G; Grasl C; Stoiber M; Rieder E; Kasimir MT; Dunkler D; Simon P; Weigel G; Schima H
    Artif Organs; 2008 Jan; 32(1):28-35. PubMed ID: 18181800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves.
    Korossis SA; Booth C; Wilcox HE; Watterson KG; Kearney JN; Fisher J; Ingham E
    J Heart Valve Dis; 2002 Jul; 11(4):463-71. PubMed ID: 12150291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep.
    Hilbert SL; Yanagida R; Souza J; Wolfinbarger L; Jones AL; Krueger P; Stearns G; Bert A; Hopkins RA
    J Heart Valve Dis; 2004 Sep; 13(5):831-40. PubMed ID: 15473487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of tissue engineered human heart valves using autologous progenitor cells.
    Cebotari S; Lichtenberg A; Tudorache I; Hilfiker A; Mertsching H; Leyh R; Breymann T; Kallenbach K; Maniuc L; Batrinac A; Repin O; Maliga O; Ciubotaru A; Haverich A
    Circulation; 2006 Jul; 114(1 Suppl):I132-7. PubMed ID: 16820562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor.
    Juthier F; Vincentelli A; Gaudric J; Corseaux D; Fouquet O; Calet C; Le Tourneau T; Soenen V; Zawadzki C; Fabre O; Susen S; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):843-52. PubMed ID: 16580443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study.
    Hong H; Dong N; Shi J; Chen S; Guo C; Hu P; Qi H
    Artif Organs; 2009 Jul; 33(7):554-8. PubMed ID: 19566733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of heart valve scaffold and cell seeding].
    Long L; Wu C; Pan L; Qi X; Hong T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Aug; 21(4):610-3. PubMed ID: 15357443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.